ASO Author Reflections: Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Zhang, Shi-Rong [1 ,2 ,3 ,4 ]
Li, Hao [1 ,2 ,3 ,4 ]
Wang, Wen-Quan [1 ,2 ,3 ,4 ]
Liu, Liang [1 ,2 ,3 ,4 ]
Yu, Xian-Jun [1 ,2 ,3 ,4 ]
机构：
[1] Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Shanghai Pancreat Canc Inst, Shanghai, Peoples R China
[4] Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China
来源：
ANNALS OF SURGICAL ONCOLOGY | 2018年 / 25卷 / 13期
关键词：
METASTASIS;
D O I：
10.1245/s10434-018-6737-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3994 / 3995
页数：2
相关论文
共 50 条
  • [41] A Single-Cell Atlas of Tumor-Infiltrating Immune Cells in Pancreatic Ductal Adenocarcinoma
    Wang, Hao
    Chen, Lu
    Qi, Lisha
    Jiang, Na
    Zhang, Zhibin
    Guo, Hua
    Song, Tianqiang
    Li, Jun
    Li, Hongle
    Zhang, Ning
    Chen, Ruibing
    MOLECULAR & CELLULAR PROTEOMICS, 2022, 21 (08)
  • [42] ASO Author Reflections: Lymphocyte-to-monocyte ratio as prognostic biomarker in pancreatic ductal adenocarcinoma
    Kubota, Koji
    Shimizu, Akira
    Soejima, Yuji
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (02) : 1449 - 1450
  • [43] ASO Author Reflections: Lymphocyte-to-monocyte ratio as prognostic biomarker in pancreatic ductal adenocarcinoma
    Koji Kubota
    Akira Shimizu
    Yuji Soejima
    Annals of Surgical Oncology, 2022, 29 : 1449 - 1450
  • [44] Clinical significance of tumor-infiltrating conventional and plasmacytoid dendritic cells in pancreatic ductal adenocarcinoma
    Plesca, Ioana
    Benesova, Iva
    Beer, Carolin
    Sommer, Ulrich
    Mueller, Luise
    Wehner, Rebekka
    Heiduk, Max
    Aust, Daniela
    Baretton, Gustavo
    Bachmann, Michael P.
    Feldmann, Anja
    Weitz, Juergen
    Seifert, Lena
    Seifert, Adrian M.
    Schmitz, Marc
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 76 - 76
  • [45] Clinical significance of tumor-infiltrating conventional and plasmacytoid dendritic cells in pancreatic ductal adenocarcinoma
    Plesca, I.
    Benesova, I.
    Beer, C.
    Sommer, U.
    Mueller, L.
    Wehner, R.
    Heiduk, M.
    Aust, D.
    Baretton, G.
    Bachmann, M. P.
    Feldmann, A.
    Weitz, J.
    Seifert, L.
    Seifert, A. M.
    Schmitz, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 65 - 65
  • [46] Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma
    Plesca, Ioana
    Benesova, Iva
    Beer, Carolin
    Sommer, Ulrich
    Mueller, Luise
    Wehner, Rebekka
    Heiduk, Max
    Aust, Daniela
    Baretton, Gustavo
    Bachmann, Michael P.
    Feldmann, Anja
    Weitz, Juergen
    Seifert, Lena
    Seifert, Adrian M.
    Schmitz, Marc
    CANCERS, 2022, 14 (05)
  • [47] Tumor-infiltrating platelets promote the growth of lung adenocarcinoma
    Li, Xiaohui
    Li, Ming
    Hu, Ziming
    Zhou, Li
    Zheng, Meijuan
    Jiao, Defeng
    Qin, Jingkun
    Fu, Binqing
    Zheng, Xiaohu
    Wei, Haiming
    TRANSLATIONAL ONCOLOGY, 2024, 39
  • [48] Prognostic Significance of Tumor-infiltrating Lymphocytes on Survival Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis
    Tan, Harold N. C.
    Catedral, Lance I. G.
    San Juan, Michael D.
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (01) : 29 - 40
  • [49] ASO Author Reflections: Are Tumor-Infiltrating Neutrophils Drivers of Metastatic Disease in Esophageal Cancer Patients Treated with Neoadjuvant Therapy?
    Carlos S. Cabalag
    Wayne A. Phillips
    Cuong P. Duong
    Nicholas J. Clemons
    Annals of Surgical Oncology, 2023, 30 (3) : 1626 - 1627
  • [50] ASO Author Reflections: Are Tumor-Infiltrating Neutrophils Drivers of Metastatic Disease in Esophageal Cancer Patients Treated with Neoadjuvant Therapy?
    Cabalag, Carlos S.
    Phillips, Wayne A.
    Duong, Cuong P.
    Clemons, Nicholas J.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (03) : 1626 - 1627
12345